Spring 2006 Seminars

Microbiology Seminar Series

Spring 2006

Date Speaker, Affiliation, Title Host, Location
2/15 John Nicolas, Ph.D.
Signal Transduction by Human Herpesvirus-8 Interleukin-6
Dean Kedes, MD Ph.D.
2/22 Dr. Robert Liddington
Burnham Institute “Pathogen Subversion of Hosting Signaling Pathways”
Zygmunt Derewenda, MSc, PhD
Professor of Molecular Physiology and Biological Physics
University of Virginia School of Medicine
and the Department of Microbiology
Microbiology Student Rotation Talks Amy Bouton, Ph.D.
3/22 Nahum Meller, Ph.D.,
University of Virginia
Candidate for an appointment as Research Assistant Professor in Microbiology
“The nonconventional Ddc42-GEF Zizimin1 – functions & mechanism of action.”
Martin A. Schwartz, Ph.D.
3/29 Michael W. Cruise,
Recipient of the Fourth Annual “Robert R. Wagner Prize” for outstanding research in Microbiology
“Enhanced FasL expression by HCV core induces the production of CXCR3 chemokines and liver damage”
Location:  Jordan Hall Conference Center
Tom Parsons, Ph.D.
Krishan J. Hudson, Ph.D. Candidate
” The Mechanisms and Functions of the Yersinia pseudotuberculosis Outer Membrane Adhesins Invasin and YadA in Phagocytic Uptake and Systemic Infections”
Room 7006 Jordan Hall
Amy Bouton, Ph.D.
4/12 Linton M. Traub, Ph.D.
Associate Professor Department of Cell Biology and Physiology University of Pittsburgh School of Medicine
“The complex web of cargo-selective adaptors for clathrin-mediated endocytosis”
Jim Casanova, Ph.D.
David W. Mullins, Ph.D.
Assistant Professor of Research
“Enhancing immune-mediated control of metastatic melanoma:  cancer immunotherapy research at the nexus of basic and translational science”
Tom Parsons, Ph.D.
4/19 Dr. Gail Wertz, Professor,
Dept. of Pathology, University of Virginia
“Transcriptional Control Is Pivotal for Negative Strand RNA Virus Pathogenesis”
Kodi Ravichandran, Ph.D.
4/26 Benjamin Neel, M.D., Ph.D.
Director, Cancer Biology Program
Beth Israel Deaconess Medical Center, Boston
“SH2-containing tyrosine phosphates in health and disease”
Kodi Ravichandran, Ph.D.
5/3 David Brautigan, Ph.D.
Director, Center for Cell Signaling at University of Virginia
“Connecting Kinases and Phosphatases in Cell Signaling”
Kodi Ravichandran, Ph.D.
 5/8  Borna Mehrad, MD
University of Texas Southwestern Medical Center Division of Pulmonary and Critical Care Medicine
“CCR6 and dendritic cell traffic in a mouse model of invasive aspergillosis”
 J.T. Parsons, Ph.D.
5/17 Carol A. Lange, Ph.D.
Associate Professor of Medicine and Pharmacology, University of MN Cancer Center
“Integration of Progesterone Receptor and Mitogenic Kinase Signaling Pathways in Breast Cancer Cell Models”
Deborah Lannigan, Ph.D.
Fiona J. Pixley, M.B., B.S., Ph.D.
Instructor  Department of Anatomy & Structural Biology, Albert Einstein College of Medicine
“CSF-1 Regulation of Macrophage Adhesion, Motility and Enhancement of Tumor Invasion”
 Amy Bouton, Ph.D.
5/24 Dr. Mani Mahadevan
Associate Professor, Dept. of Pathology and Biochem & Molecular Genetics,
Medical Director, Molec. Diagnostics Lab, UVA Health System
Associate Director, Cytogenetics Lab, UVA-Health System
University of Virginia
“RNA Toxicity in Disease Pathogenesis”
Kodi Ravichandran, Ph.D.
Robert N. Trotter
Dept. of Microbiology, University of Virginia
Central and Peripheral Circuits Regulating Thymopoiesis in the Mouse and Rat”
 Margo Roberts, Ph.D.
Dr. Matthew Krummel,
Associate Professor, UCSF
“Spatiotemporal Control of T cell Motility, Polarity and Activation”
Ian Macara, Ph.D.
Jan van Deursen, Ph.D.
Mayo Clinic Rochester
Department of Pediatrics and Adolescent Medicine
“Role of CBP and P300 in Breast Cancer Development “